Uterine Atony Clinical Trial
Official title:
Novel Approach of Hayman Uterine Compression Sutures for Management of Severe Atonic Postpartum Hemorrhage: Three Vertical Sutures
Maternal deaths due to uterine atony bleeding are the leading causes of maternal death in our country and all over the world. In this respect, our clinic is among the clinics with the highest number of experience in our country and aims to reduce maternal deaths and mothers who will need intensive care due to bleeding with a hemorrhage stopping technique that will have a serious contribution to both our country and the world literature. Our primary goal, thanks to the bleeding-stopping technique, to reduce their deaths. Our secondary aim is, thanks to the bleeding-stopping technique we offer, To prevent and reduce the complications seen in mothers during the operative period.
Our research was carried out to our obstetrics clinic between 01 Agustus 2015 - 01 December 2020. Patients transplanted due to postpartum bleeding and patients requiring surgery due to abnormal postpartum bleeding in our clinic will be included. Patients with a previously known bleeding disorder will not be included in the study. In our study, the parameters of the patients who had bleeding due to postpartum uterine atony and who needed uterine surgery previously underwent triple Hayman compression suture to stop bleeding will be included in the study. Patients with a triple Hayman suture covering the upper 2/3 of the uterus to stop uterine bleeding will be evaluated in the study. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Enrolling by invitation |
NCT02910115 -
Cooling the Uterus in C-section After Dysfunctional Labor
|
N/A | |
Withdrawn |
NCT02410655 -
An Evidence Based Protocol for Oxytocin Administration in Vaginal Delivery
|
Phase 4 | |
Completed |
NCT00790062 -
Oxytocin Regimen to Prevent Atony and Postpartum Hemorrhage During Vaginal Delivery: 3-arm RCT
|
Phase 4 | |
Recruiting |
NCT01579201 -
ED90 Determination of Carbetocin for the Prevention of Uterine Atony in Women Undergoing an Elective Cesarean Delivery
|
Phase 4 | |
Completed |
NCT03867383 -
Calcium Chloride for Prevention of Uterine Atony During Cesarean
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT03584854 -
Second-Line Uterotonics in Postpartum Hemorrhage: A Randomized Clinical Trial
|
Phase 4 | |
Completed |
NCT02780245 -
Role of Tranexamic Acid Versus Uterine Cooling at Caesarean Section
|
Phase 4 | |
Completed |
NCT00785395 -
Up-Down Oxytocin Infusion
|
Phase 4 | |
Withdrawn |
NCT03303235 -
Intravenous Versus Intramuscular Administration of Methylergonovine for Uterine Contraction in Cesarean Sections
|
Early Phase 1 | |
Completed |
NCT02229513 -
Uterine Cooling During Cesarean Delivery to Reduce Blood Loss and Incidence of Postpartum Hemorrhage
|
N/A | |
Not yet recruiting |
NCT06192836 -
Placental Removal Method And Uterine Massage On Preventing Postpartum Hemorrhage
|
||
Recruiting |
NCT03413917 -
Exploration and Determination of Genomic Markers Predictive of Uterine Atony
|
||
Withdrawn |
NCT01252342 -
Does Intramyometrial Oxytocin Improve Outcome in Elective Cesarean Delivery?
|
Phase 4 | |
Completed |
NCT05027048 -
Calcium Chloride for Prevention of Blood Loss During Intrapartum Cesarean Delivery
|
Phase 3 | |
Completed |
NCT01630187 -
Comparison of Two Doses of Carbetocin for Prevention of Uterine Atony, During Elective Cesarean Section
|
Phase 4 | |
Completed |
NCT01549223 -
Oxytocin And Uterotonic Agent Use For Cesarean Delivery
|
Phase 4 |